aut00063
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2014 (NCT02315508)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- aut00063
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02832128 | Phase 2 | May 1, 2016 | Autifony Therapeutics Limited, Royal National Throat, Nose and Ear Hospital |
| NCT02345031 | Phase 2 | Jan 1, 2015 | Autifony Therapeutics Limited |
| NCT02315508 | Phase 2 | Oct 1, 2014 | Autifony Therapeutics Limited, Sheffield Hallam University, University of Nottingham |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Autifony Therapeutics Limited | For profit | 3 | 3 | 1 | 2014 |
| Royal National Throat, Nose and Ear Hospital | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Sheffield Hallam University | Academic/Hospital | 1 | 0 | 1 | 2014 |
| University of Nottingham | Academic/Hospital | 1 | 0 | 1 | 2014 |
4 organizations
Page 1 / 1